Pharmacy Medical News about Phosphodiesterase

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anti-lipase and lipolytic activities of ursolic acid isolated from the roots of Actinidia arguta
Archives of Pharmacal Research, 08/10/09

Kim J et al. – The authors suggest that the inhibitory effects of ursolic acid, isolated from the roots of A. arguta, on obesity, might be attributable to the inhibition of lipid absorption through the inhibition of pancreatic lipase and by enhancing lipolysis in fat cells.

<< Previous
Analysis of Fuzhisan and quantitation of baicalin and ginsenoside...

Next >>
Studies on the formation of hydrophobic ion-pairing complex of...

Platelet Cyclic Guanosine Monophosphate as a Biomarker of Phosphodiesterase Type 5 Inhibitor Efficacy in the Treatment of Erectile Dysfunction: A Randomized Placebo-Controlled Study
European Urology, 11/05/09 Relevance Score: 85%

Oral Phosphodiesterase-5 Inhibitors and Hormonal Treatments for Erectile Dysfunction: A Systematic Review and Meta-analysis
Annals of Internal Medicine, 10/23/09 Relevance Score: 82%

A Randomised, Double-Blinded, Placebo-Controlled Study of the Phosphodiesterase Type 5 Inhibitor Sildenafil for the Treatment of Preeclampsia
Hypertension in Pregnancy, 10/30/09 Relevance Score: 80%

Guidelines Urge Use of Erectile Dysfunction Drugs
Internet Source, 10/29/09 Relevance Score: 80%

Studies show Viagra, other drugs outperform hormone treatment
Internet Source, 10/21/09 Relevance Score: 80%